Induction of a proinflammatory cytokine, interleukin1b (IL-1b) plays a role in memory impairment associated with various neurological disorders and brain injury. Here we show that IL-1b-induced memory impairment in brain is mediated by hydrogen sulfide (H 2 S) synthesized by cystathionine beta-synthase (CBS). H 2 S modifies GAPDH essentially via sulfhydration in dendrites, which promotes its binding to the E3 ligase protein, Siah. Then Siah binds to a critical synaptic scaffolding molecule, PSD95, and leads it to degradation via ubiquitination. In CBS heterozygous mice (cbs +/À ) and primary neurons depleted with either CBS or IL-1R, IL-1b-induced loss of PSD95 was rescued along with a decrease in the level of GAPDH sulfhydration. Moreover, decrease in the loss of PSD95 in cbs +/À mice results in improvement of IL-1b-induced cognitive deficits and neurobehavioral outcomes. Thus, our findings reveal a mechanism where GAPDH sulfhydration appears to be a physiologic determinant of cytokine-induced memory impairment in brain.
INTRODUCTION
Postsynaptic density 95 (PSD95), an important scaffold protein (Cheng et al., 2006; Kim and Sheng, 2004) , is known to promote synapse maturation and exerts a major influence on synaptic stability, strength, and plasticity (El-Husseini et al., 2000; Elias et al., 2006) . Moreover, overexpression of PSD95 directly influences long-term potentiation (LTP) in brain (Bé ïque and Andrade, 2003; Ehrlich and Malinow, 2004; Stein et al., 2003) . Spines with low levels of PSD95 are more susceptible to activity-dependent alterations in spine shape (Steiner et al., 2008) , and the loss of PSD95 leads to spine retraction (Cane et al., 2014; Ehrlich et al., 2007) , which has been implicated in several brain diseases, such as depression, addiction, dementia, and anxiety disorders.
We propose that induction of proinflammatory cytokine interleukin-1b (IL-1b) results in degradation of PSD95 via a H 2 Sdependent manner. IL-1b is a proinflammatory cytokine that is expressed in multiple cell types in the brain, and IL-1b signaling within the brain plays a critical role in learning and memory processes (Gemma and Bickford, 2007) . In the brain, high concentrations of IL-1b act upon neurons to inhibit synaptic strength and LTP (Williamson and Bilbo, 2013) , while physiological levels of IL-1b promote LTP and memory formation (McAfoose and Baune, 2009) . Moreover, within the brain, IL-1b mediates illness-associated neural, neuroendocrine, and behavioral responses; however, its role in neurobehavioral processes is not clear (Cheng et al., 2012; Jones and Thomsen, 2013; Loddick et al., 1998; Marin and Kipnis, 2013) .
Hydrogen sulfide (H 2 S), a newly discovered gasotransmitter Paul and Snyder, 2012; Wagner et al., 2009; Wang, 2003) , is generated in the periphery by cystathionine g-lyase (cystathionase; CSE), while in the brain its biosynthesis primarily involves cystathionine b-synthase (CBS) (Kimura, 2010; Szabó , 2007) . H 2 S appears to signal predominantly by sulfhydrating cysteines of its target proteins, such as GAPDH and actin, which leads to augmentation of GAPDH catalytic activity and actin polymerization , thereby altering functions of a wide range of cellular proteins and enzymes .
In the present study, we show that IL-1b stimulates the transcription of CBS, and the generated H 2 S predominantly sulfhydrates GAPDH at its cysteine 150 (C150), enhancing its binding to the E3 ligase Siah, thereby augmenting degradation of PSD95. In CBS-deficient mice, GAPDH cannot be sulfhydrated. As a result, degradation of PSD95 will be decreased, and IL-1b memory impairment will be restored. Thus, H 2 S-induced modification of GAPDH appears to be an essential posttranslational modification of GAPDH that is required for IL-1b-induced synapse loss in brain.
RESULTS

CBS Is Responsible for IL-1b-Induced Loss of PSD95 and Neurological Impairments
To characterize the influence of CBS on IL-1b-induced neurological outcomes, rotarod and Morris water maze (MWM) tests were performed after administration of IL-1b in cortex. We found that the number of falls per min ( Figure 1A ) decreased and latency to first fall ( Figure 1B ) increased during rotarod tests in cbs +/À mice compared to wild-type cbs +/+ mice. While the latency to find the platform ( Figure 1C ) reduced in the cbs +/À mice compared to cbs +/+ mice, the time spent in right quadrant ( Figure 1D ) in the MWM test was increased. These data suggest that the depletion of CBS directly influences IL-1b-induced cognitive deficits in mice. However, the total level of interleukin IL-1b receptor (IL-1R) remained unaltered in both cbs +/+ and cbs +/À mice, which was evidenced by both western blot ( Figure S1A , available online) and confocal microscopic analysis ( Figure S1B ). To monitor whether IL-1b has any direct influence on the level of PSD95, we treated cbs +/+ and cbs À/À neurons with IL-1b. We found that the level of PSD95 was significantly decreased in cbs +/+ neurons ( Figure 1E ) compared to cbs À/À ( Figure S1C ) after treatment with IL-1b. Moreover, total number of PSD95 positive puncta ( Figures 1F, 1Ga , and 1Gb) and size of PSD95 puncta ( Figures 1F and 1Gc ) were decreased significantly in cbs +/+ neurons compared to cbs À/À (Figures S1D and S1Ea-S1Ec) after treatment with IL-1b. However, treatment with IL-1b does not affect the protein level of a presynaptic protein synapsin (Figures S1F and S1G) or IL-1R level ( Figure S1H ) in neurons and in vivo ( Figure S1I ). Consistent with this result, depletion of CBS via administration of lentiviral particles of CBS RNAi also leads to a decrease in the loss of PSD95 after treatment with IL-1b ( Figures 1H and 1I) . Similarly, the decrease in the number (Figures 1I, 1Ja, and 1Jb) and size of PSD95 puncta ( Figures 1I and 1Jc ) was rescued in the neurons depleted with CBS. Consistent with depletion of CBS via lentiviral particles, depletion of CBS via administration of esiRNA for CBS also resulted in a reduction in the decrease in the level of PSD95 ( Figure S1J ) and the number (Figures S1J, S1Ka, and S1Kb) and size ( Figure S1Kc ) of PSD95 puncta. Taken together, these results suggest that IL-1b directly influences PSD95 level in a CBS-dependent manner.
To see whether loss of PSD95 has a similar effect on memory formation in both cbs +/+ and cbs +/À mice, we depleted PSD95 in cortex and subjected them to both rotarod and MWM tests. The loss of PSD95 in brain was confirmed by confocal analysis (Figure 1K) . We found that depletion of PSD95 causes an increase in the number of falls per min ( Figure 1L ) and decreased latency to first fall ( Figure 1M ) during rotarod tests in both group of mice. In MWM tests, the latency to find the platform ( Figure 1N ) was significantly increased in mice depleted with PSD95 in both cbs +/+ and cbs +/À mice. Moreover, mice depleted with PSD95 spent less time in the right quadrant in MWM tests ( Figure 1O ).
IL-1b-Induced Increase in H 2 S Causes Loss of PSD95 in Neuron
To see whether IL-1b has any direct influence on CBS protein level in brain, we found that treatment with IL-1b leads to a significant increase in CBS protein level in a dose-dependent manner. However, the level of other H 2 S synthesizing enzymes, such as CSE, remains unaltered after IL-1b treatment ( Figure 2A ).
Since IL-1b functions through its receptor (IL-1R), we depleted IL-1R in primary neurons, and CBS protein level was measured after treatment with IL-1b. We found that in the absence of IL-1R ( Figures 2C and S2A ), IL-1b-induced induction of CBS protein level was abolished ( Figure 2B ), as evidenced by confocal microscopy analysis. We also found that the treatment with IL-1b leads to a 2-fold increase in mRNA level of CBS; however, depletion of IL-1R in primary neurons abolished the IL-1b-induced increase in mRNA level of CBS ( Figures 2D and S2B ), suggesting that CBS was increased due to an increase in its transcriptional activity. Since CBS is known to be transcriptionally regulated by Sp1 (Maclean et al., 2004; Wu et al., 2010) , we monitored the influence on Sp1 binding to CBS promoter by ChIP assay in both control RNAi and IL-1R RNAi-treated cells. We found that binding of Sp1 to CBS promoter was increased significantly in cells treated with IL-1b ( Figure 2E ); however, depletion of IL-1R prevents Sp1 binding to the CBS promoter. Moreover, depletion of Sp1 prevents an IL-1b-induced increase in the level of CBS protein levels in neurons ( Figures 2F and S2C ).
Since the activation of Sp1 depends on its phosphorylation (Tan and Khachigian, 2009 ), we also monitored whether IL-1b has any influence on its phosphorylation level. We found that treatment with IL-1b elicits an increase in phosphorylation of Sp1 ( Figure S2D) ; however, depletion of IL-1R causes a decrease in the induction ( Figure S2E ). These data suggest that IL-1b causes an upregulation of CBS protein level by augmenting its mRNA level.
Since CBS synthesizes H 2 S, we measured intracellular H 2 S level using a membrane-permeable probe, WSP1, that can emit green fluorescence upon its reaction with H 2 S (Liu et al., 2011; Peng et al., 2014) . We found that treatment with IL-1b leads to an increase in green fluorescent intensity of WSP1 greater than 2.5-fold ( Figures 2G and S2F) . However, the IL-1b-induced increase in WSP1 intensity was decreased significantly (Figures 2G and S2G) in the neurons depleted with CBS ( Figure S2H ). Moreover, depletion of IL-1R decreases the IL-1b-induced increase in H 2 S level (Figures S2I and S2J) . The increase in green fluorescent intensity of WSP1 linearly with increasing concentration of GYY4137 in human embryonic kidney 293 (HEK293) cells ( Figure S2K ) confirms the specificity of WSP1 toward H 2 S. Moreover, the overexpression of CBS in HEK293 cells leads to an increase in WSP1-mediated fluorescence intensity, which further confirms the selectivity of WSP1 toward H 2 S ( Figure S2L ).
CBS is known to catalytically convert homocysteine (hcy) to H 2 S through the transsulfuration pathway (Kimura, 2010) . To see whether hcy directly influences PSD95 level in neurons, we treated primary neurons with hcy and found that treatment with Figure 2Ic ). This can be explained by the fact that either hcy itself or excess H 2 S, generated by the addition of hcy via catalytic activity of CBS, leads to the loss of the PSD95. To test our hypothesis, we treated neuron with hcy after depletion of CBS by RNAi and we found that treatment with hcy was unable to decrease PSD95 level or reduce the number and size of PSD95 puncta in cells depleted with CBS. These data indicate that generation of excess H 2 S is responsible for the phenotype.
To further confirm the influence of H 2 S on PSD95 level, we treated primary neurons with H 2 S donor GYY4137 and found that, similar to treatment with hcy, GYY4137 leads to a significant decrease in PSD95 puncta number ( 
IL-1b-Induced Sulfhydration of GAPDH Forces Degradation of PSD95 via Siah
We found that an IL-1b-induced increase in H 2 S modifies GAPDH predominantly through sulfhydration (GAPDH-SSH) in neurons isolated from cbs +/+ mice; however, depletion of CBS leads to a significant decrease in the level of GAPDH-SSH (Figures 3A and S3A) , which was confirmed by both maleimide assay and modified biotin switch assay, respectively. We used maleimide because it interacts selectively with free sulfhydryl groups of cysteines, labeling both sulfhydrated (ÀSSH) as well as unsulfhydrated (ÀSH) cysteines. The samples are treated with dithiothreitol (DTT), which selectively cleaves disulfide bonds and so will detach the red signal from sulfhydrated, but not unsulfhydrated, protein, resulting in decreased fluorescence ( Figure S3B ). The percentage of GAPDH sulfhydration was quantitated by dividing the residual red fluorescence intensity after DTT treatment by the total level of GAPDH following the procedure published elsewhere (Figure S3B ). Previously, liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis suggested that GAPDH can be sulfhydrated at the Cys150 (C150) residue . Consistent with our previous finding, we found that overexpression of GAPDH-C150S abolished GYY4137-induced sulfhydration of GAPDH ( Figure 3B ).
We found that treatment with IL-1b leads to an increase in interaction between GAPDH and Siah ( Figures 3C and S3C) , which results in stabilization of Siah ( Figures 3D and S3D ). However, the interaction between GAPDH and Siah was decreased significantly in IL-1b-treated neurons depleted with CBS ( Figures  3C and S3C ) along with the destabilization of Siah protein (Figures 3D and S3D) . To further confirm whether the H 2 S-modified GAPDH is directly responsible for interaction between Siah and GAPDH, we overexpressed either GAPDH or GAPDH-C150S in HEK293 cells followed by treatment with GYY4137. The interaction between Siah and GAPDH was substantially increased in cells overexpressed with GAPDH after treatment with GYY4137; however, the overexpression of GAPDH-C150S abolished the Siah-GAPDH interaction (Figures 3E and S3E) . These results suggest that sulfhydration of GAPDH is responsible for its interaction with Siah.
To see whether Siah can directly interact with PSD95, we monitored the Siah-PSD95 interaction by both immunoprecipitation (IP) and confocal microscopic analysis. We found that after treatment with IL-1b, the interaction between Siah and PSD95 in the spines increased significantly ( Figures 3F, 3G , and S3F), along with an increase in Siah protein level (Figures 3F and 3G) . However, the depletion of CBS in the neurons uncouples the Siah-PSD95 interaction (Figures 3F and 3G) and reduces the protein level of Siah ( Figures 3G and 3H) significantly. Treatment with either hcy (Figures S3G and S3H) or GYY4137 (Figures S3I and S3J) leads to an increase in both Siah-PSD95 interaction and loss of PSD95 level in wild-type neurons; however, it was prevented in neurons depleted with CBS protein. Unlike hcy treatment, the GYY4137-induced increase in Siah-PSD95 interaction and loss of PSD95 level were not rescued in CBSdepleted cells (Figures S3I and S3J) , which suggests that H 2 S, but not hcy, is directly responsible for the interaction between Siah and PSD95.
Since Siah degrades proteins via ubiquitination, we monitored whether stabilization of Siah lead to ubiquitination of PSD95 in the neurons treated with IL-1b ( Figure 3I ). We found that IL-1b causes ubiquitination of PSD95; however, it was abolished in cells depleted with CBS ( Figure 3J ). The degradation of PSD95 was prevented by treatment with a proteasomal inhibitor, (O) Western blot analysis of PSD95 after GYY4137 treatment following depletion of CBS. *p < 0.01, n = 10-12, mean ± SEM, Student's t test. Please see Figure S2 . Figure 3K ), which suggests that PSD95 is polyubiquitinated in neurons treated with IL-1b. We found that IL-1b-induced degradation of PSD95 was reduced along with decrease in the loss of PSD95 puncta number ( Figures 3L, 3M , 3Na, and 3Nb) and the size of PSD95 puncta (Figure 3Nc ) after depletion of Siah in neurons. These data suggest that ubiquitination of PSD95 is directly regulated by Siah. In another set of experiments, overexpressing catalytically inactive Siah (Siah deleted with catalytic RING domain) was unable to ubiquitinate PSD95 in the neurons treated with GYY4137 compared to the cells overexpressing wild-type Siah ( Figure 3O ). Since IL-1b stabilizes Siah in a GAPDH-SSH-dependent manner, we overexpressed PSD95 along with either GAPDH or GAPDH-C150S in HEK293 cells. We found that GYY4137-induced ubiquitination of PSD95 was augmented in cells overexpressed with wild-type GAPDH compared to cells overexpressed with GAPDH-C150S ( Figure 3P ). Taken together, these data suggest that anIL1b-induced increase in GAPDH sulfhydration results in stabilization of Siah protein, which in turn binds with PSD95 and degrades it through the process of ubiquitination in neurons.
IL-1b-Induced Synapse Loss Was Rescued in cbs +/-Mice
We monitored intracellular H 2 S level in the cortex of both cbs
and cbs +/À mice with or without treatment of IL-1b. We found that H 2 S level was increased to 2.8-fold in cbs +/+ mice after administration of IL-1b. In cbs +/À mice, the physiological level of H 2 S level was 0.3-fold compared to that of cbs +/+ mice. However, the H 2 S level was increased to 0.9-fold in cbs +/À mice following IL-1b treatment ( Figure 4A ). Moreover, consistent with primary neuron data, we found that IL-1b modifies GAPDH essentially via sulfhydration in cbs +/+ mice; however, the effect was reduced in cbs +/À mice significantly ( Figure 4B ). Since sulfhydration of GAPDH is critical for its interaction with Siah, we measured the GAPDH-Siah interaction by IP using lysates of cortex of both cbs +/+ and cbs +/À mice. We found that IL-1b augments the interaction between Siah and GAPDH in cbs +/+ mice compared to cbs +/À mice ( Figure 4C ). The interaction between Siah and PSD95 was also increased in cbs +/+ mice after treatment with IL-1b; however, the interaction was decreased significantly in cbs +/À mice ( Figure 4D ). We also found that treatment with IL-1b leads to a decrease in PSD95 in cbs +/+ mice; however, the level of PSD95 was not reduced in cbs +/À mice after treatment with IL-1b ( Figures 4E and 4F) . Moreover, the spine number was significantly decreased in cbs +/+ brain after IL-1b treatment;
however, loss of spines was rescued in IL-1b-induced cbs +/À mice ( Figure 4G ). Previously, we have shown that nitrosylated GAPDH is acetylated in the nucleus by the acetyltransferase p300 through direct protein-protein interaction, which in turn stimulates the acetylation of p53 that leads to cell death . To monitor whether treatment with IL-1b has any influence on nitrosylation of GAPDH, we treated primary neurons with IL-1b in a timedependent manner. We found that sulfhydration of GAPDH is followed by nitrosylation of GAPDH ( Figure S4A ). On the other hand, PSD95 level ( Figures S4B, S4Ca , S4Cb, and S4D) and size of the PSD95 puncta ( Figure S4Cc ) were lost within 3 to 8 hr of IL-1b treatment; however, cell death was initiated after 8 hr and peaked at 24 hr after IL-1b treatment ( Figure S4E ). Depletion of CBS in cells causes a decrease in the level of GAPDH sulfhydration ( Figure S4F ) and loss of PSD95 (Figure S4G ), but nitrosylation of GAPDH ( Figure S4F ) and cell death ( Figure S4H ) remain unaltered following IL-1b treatment. These data indicate that sulfhydration of GAPDH does not influence cell death. One possible explanation was that modified GAPDH cannot activate p53 to cause cell death.
To test our hypothesis, we measured GAPDH-p300 interaction along with acetylation of p300 and p53 in IL-1b-treated primary neurons in a time-dependent manner. We found that acetylation of GAPDH, p300, and p53 was increased after 12 hr of IL-1b and was further increased after 24 hr ( Figures S4I and S4J) . Similarly, the interaction between GAPDH and p300 was detectable after 8 hr of IL-1b, and it was increased further to 24 hr of IL-1b treatment ( Figure S4K ). Moreover, acetylation of p53 remains unaltered in cells depleted with CBS compared to control RNAi-treated cells ( Figure S4L ). These data suggest that since sulfhydrated GAPDH cannot interact with p300, it does not activate p53 and cell death. This was further confirmed by in vitro glutathione S-transferase (GST) pull-down assay where sulfhydrated GAPDH was unable to interact with recombinant p300; however, nitrosylated GAPDH interacts strongly with p300 ( Figure S4M ). Taken together, our data establish that sulfhydrated GAPDH does not induce cell death like nitrosylated GAPDH after IL-1b treatment. (E and F) Western blot hybridization (E) and confocal microscopic analysis (F) to detect PSD95 level in the IL-1b-injected cbs +/+ and cbs +/À mice.
(G) Analysis of spine number in cbs +/+ and cbs +/À mice after Golgi-Cox metal impregnation.
(H) A model represents how IL-1b leads to spine loss. Briefly, IL-1b induces intracellular H 2 S due to an increase in the level of protein level of CBS, which in turn essentially sulfhydrates GAPDH. Then, the modified GAPDH stabilizes Siah, which interacts with PSD95 and results in the degradation of PSD95 by ubiquitination. The loss of PSD95 leads to spine loss. *p < 0.01, n = 3, mean ± SEM, one-way ANOVA. Please see Figure S4 .
DISCUSSION
In summary, our findings establish a signaling pathway whereby IL-1b causes degradation of PSD95 in a H 2 S-dependent manner. Augmentation in the level of H 2 S modifies GAPDH predominantly via sulfhydration, which causes an increase in its interaction with Siah. The stabilized Siah binds with PSD95 and leads it to degradation ( Figure 4H ). In cbs +/À mice, IL-1b-induced sulfhydration of GAPDH was attenuated, and as a result the loss of PSD95 and synaptic density were reduced significantly.
We excluded cbs À/À mice from our study related to IL-1b treatment in vivo because they are lethal 4-5 weeks after their birth.
The cbs +/À mouse has an elevated level of homocysteine and a reduced level of H 2 S. Interestingly, we found that treating primary neurons with hcy causes the loss of PSD95; however, it was rescued in cells depleted with CBS. In contrast, treatment with H 2 S donor GYY4137 leads to loss of PSD95 in both control RNAi and CBS RNAi-treated cells, suggesting that H 2 S, not hcy, is directly responsible for PSD95 loss. We have also shown that treatment with GYY4137 facilitates the interaction between PSD95 and Siah protein in both control RNAi and CBS RNAitreated cells. Thus, the decrease in PSD95 loss in cbs +/À mice may be explained by the reduced H 2 S level rather than the elevated hcy level.
The level of sulfhydration of GAPDH was measured by maleimide assay and further confirmed by modified biotin switch assay. An advantage of maleimide assay is that it cannot detect oxidized, nitrosylated, or disulfide-linked modification of proteins. The similarity of results with the maleimide and modified biotin switch methods supports the reliability of the two techniques as assays for the identification of GAPDH modification following H 2 S treatment.
After IL-1b treatment, sulfhydration of GAPDH occurs first, leading to an early loss of PSD95. Then, nitrosylated GAPDH leads to cell death. Degradation of PSD95 through GAPDHSiah cascade provides the physiological significance of sulfhydration of GAPDH in brain. Moreover, ubiquitination of PSD95 by Siah protein may be considered as a general mechanism for cytokine-induced loss of synaptic density and memory impairment in brain. Thus, preventing the loss of PSD95 by Siah may provide a therapeutic target against several neurodegenerative disorders and brain injury where induction of IL-1b manifests pathology of diseases, including memory loss.
EXPERIMENTAL PROCEDURES
All the animal studies conducted were according to the Committee on Animal Use for Research and Education at Georgia Regents University (GRU) in compliance with NIH guidelines. For the IL-1b injections, the male C57BL/6 mice (10-12 weeks) were divided into four groups (n = 10) as per the treatment. Both cbs +/+ and cbs +/À mice were injected with IL-1b (10 ng, Millipore), and 7 days after the injection, mice were subjected to behavioral analysis (rotor rod and water maze tests) followed by biochemical analysis. For administration of lentiviral particles for PSD95 (Santa Cruz), a similar procedure was followed, and assessment of the mice was done 15-20 days later.
Detection of Hydrogen Sulfide
The production of hydrogen sulfide (H 2 S) in primary neurons following treatment with IL-1b was detected using the fluorescence probe WSP1 according to our method .
Maleimide and Modified Biotin Switch Assay
Sulfhydration of GAPDH was monitored by both maleimide assay and biotin switch assay as described previously .
Ubiquitination of PSD95
Degradation of PSD95 was monitored following the protocol according to our method .
Synaptic Density Quantification of Primary Neurons
A total of 15-20 images from the stained neurons were acquired and analyzed using Neuron Studio (Dumitriu et al., 2011) . Quantification of spine density and size was performed following the protocol published elsewhere (Fé nelon et al., 2011) .
Golgi Cox Stain and Spine Evaluation
Mice were deeply anesthetized with isofluorane and perfused transcardially with 0.9% saline solution. The brains were removed and stained using the modified Golgi-Cox method as previously described . The detailed procedures are described in the Supplemental Information.
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Molecular Cell, Volume
Experimental Procedures:
Rotarod: To examine motor coordination and learning in the mice, a rotor-rod test was performed as described Kakegawa et al., 2011) . The mice were strictly selected with regard to body weight and eye-opening to reduce data variations. Six trials were continuously performed at 5, 20 or 4−40 rpm. After a 30s interval, the time that each mouse stayed on the rod and number of falls was measured (maximum time 120 s for the constant mode and 300 s for the accelerating mode). Trials were performed on three successive days to evaluate motor learning.
Morris Water maze test:
In the Morris water maze, the hidden platform procedure was performed in a circular tank filled with opaque water as described already with minor modifications (Vorhees and Williams, 2006) . For training, the mice (8-12 weeks) were placed in the tank at four random points and allowed to search and find the platform. In the event, the mouse didn't find the platform within the 60 s time, the mouse was manually put on platform for extra 30 s. During the trails, mouse was allowed to search for the platform for 60 s. Two trials were given every day and the latency for each trial was recorded. Probe trial was performed on day 6 or 7. The mice were allowed to swim in the tank for 60 s without the platform, and performance was assessed on the basis of the time spent in the quadrant in which the hidden platform was originally located (the right quadrant).
Cortical Primary Neuronal culture and treatment:
The preparation of the primary cortical neurons from the cbs +/+ and the cbs -/-mice was performed as described previously . The pregnant mice at the E18.5 of the gestational age based on the vaginal plug determination method were anesthetized with xylazine (8 mg/kg)/ketamine (60 mg/kg) and cleaned using 70% ethanol.
The uterus was opened and pups were placed in sterile pre-chilled HBSS. The skin biopsy was taken for the immediate genotyping for the cbs -/-pups, which were generated after breeding cbs +/-mice. Each pup was mounted on the stereomicroscope and cortices were dissected out. After enzyme based digestion, cortical neurons were counted and plated on the sterilized cover glass or 6-well plates in serum free Neurobasal Medium supplemented with appropriate growth supplements (B27 and N2 , Life Technologies). The medium was changed very 3-4 days. For the biochemical purposes, neurons were washed and scraped off and collected in lysis buffer with protease inhibitors. The protein content was estimated by Bradford method. Primary neurons were treated with either IL-1β (10 ng/ml), GYY4137
(300 µM) or homocysteine (50 µM) at indicated time points in subsequent experiments. All experiments were performed with 10-to 12-day old cultures, at which time the cultures contain ∼95-98% neurons and 2-5% astrocytes. For RNAi experiments, lentiviral RNAi particles of either CBS (sc-60336-V), Siah (sc-37496-V), IL-1R (sc-35652-V), or SP1 (sc-29488-V) were added in primary neuron following manufacturer's protocol. For the siRNA transfection (CBS esiRNA, Sigma Aldrich, USA), the 1-3µg of the siRNA was mixed with transfection reagent (Santa Cruz Biotechnology, USA) following the protocol published by others and allowed to stand for 10-20 min at the room temperature. The complexes were mixed with the supplied buffer and added to the cultures for 24-48 h and thereafter the medium was replaced.
Immunochemical Staining: Neurons were fixed with 3-4% paraformaldehyde containing sucrose for 15 min at room temperature. Cells were permeabilized using 0.1% TritonX100 in PBS (0.1M, pH 7.4) followed by blocking using serum. Thereafter the primary antibodies were applied in the blocking serum Golgi Cox Stain and spine evaluation: Mice were deeply anesthetized with isoflurane and perfused transcardially with 0.9% saline solution. The brains were removed and stained using the modified GolgiCox method as previously described . Coronal sections of 200 µm thickness from the cortex were obtained using a vibratome. These sections were collected on positive fixed microscope slides and dehydrated spontaneously. Spines were counted after image acquisition on secondary and tertiary branches of dendrites of neurons in the cortex near the IL-1β injected region. Five 10 μm segments of either secondary or tertiary dendrites were randomly selected. Spine number was measured by Image J and analyzed by investigators who were blind to protocol.
Maleimide assay: Sulfhydration of GAPDH was monitored by maleimide assay as described previously . Cortex tissues or cells treated with or without IL-1β treatment were homogenized in lysis buffer (150 mM NaCl, 0.5% v/v Tween 20, 50 mM Tris 7.5, and 1 mM EDTA) and immunoprecipitated with anti-GAPDH antibody. After washing beads with the same buffer, beads were incubated with Alexa Fluor 680 conjugated C2 maleimide (red maleimide) (2 μM, final concentration) and kept for 2 h at 4°C with occasional gentle mixing. The beads were pelleted and washed with the same buffer, then treated with or without DTT (1 mM, final concentration) for 1 h at 4°C. Beads were pelleted, washed and suspended in 2×SDS-PAGE buffer for gel electrophoresis. Gels were transferred to PVDF membranes, which were scanned with the Li-COR Odyssey system. The intensity of red fluorescence of GAPDH was quantified using software attached to the Odyssey system. These membranes were also employed for western blotting with anti-GAPDH antibody.
Modified Biotin Switch Assay for Sulfhydration:
The assay was carried out as described previously with modifications . In brief, cortex lysates or cells treated with or without IL-1β were homogenized in HEN buffer (250 mM HEPES-NaOH [pH 7.7], 1 mM EDTA, and 0.1 mM neocuproine) supplemented with 100 μM deferoxamine and centrifuged at 13,000 × g for 30 min at 4°C. Cell lysates (240 μg) were added to blocking buffer (HEN buffer adjusted to 2.5% SDS and 20 mM MMTS) at 50°C for 20 min with frequent vortexing. The MMTS was then removed by acetone and proteins precipitated at -20°C for 20 min. After acetone removal, the proteins were resuspended in HENS buffer (HEN buffer adjusted to 1% SDS). To the suspension, 4 mM biotin-HPDP was added without ascorbic acid. After incubation for 3 h at 25°C, biotinylated proteins were precipitated by streptavidinagarose beads, which were then washed with HENS buffer. The biotinylated proteins were eluted by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer and subjected to western blot analysis. For quantitation of protein sulfhydration, samples were run on blots alongside total lysates ("loads") and subjected to immunoblotting with antibodies specific to each protein.
Quantitative Real-Time PCR: Quantitative real-time PCR was performed as described previously . PCR reactions (25 μL) contained 12.5 μL of PCR Sybr Green mix (New England BioLabs) with 0.3 μM primers. At the end of the 35 cycles of amplification, a dissociation curve was performed in which Sybr Green was measured at 1°C intervals between 50°C and 100°C. Results were normalized using total input DNA and expressed as bound/Input (percentage).
S-Nitrosylation Biotin-Switch Assay: Primary neurons were treated with IL-1β (10 ng/ml) for 0, 3, 6, 8, 10 and 12 h. Then cell lysates were subjected to biotin-switch assay to detect S -nitrosylation of GAPDH as described before (Forrester et al., 2009; Jaffrey et al., 2001; . In brief, cells were lysed, and reduced cysteines were blocked with 4 mM methyl methanethionsulphonate (MMTS). Subsequently, S-nitrosylated cysteines were reduced with 1 mM ascorbate and biotinylated with 1 mM Biotin-HPDP (Pierce). The biotinylated proteins were pulled down with streptavidin agarose and analyzed by Western blotting.
